David Bourdon Email and Phone Number
David Bourdon work email
- Valid
- Valid
- Valid
David Bourdon personal email
David Bourdon phone numbers
Proactive life sciences platform developer with expertise in proteomic biomarker discovery-to-validation, immunoassay development, technology sensing, laboratory automation, cell signaling, and inflammation. Thrives in the matrix environment of working across functional teams including commercial, product management, marketing, and operations. Personal attributes include engaging personality, drive for innovation, and collaborative spirit, as well as strong interpersonal, organization, communication, and leadership skills.
Aviva Systems Biology
View-
Aviva Systems BiologySan Diego, Ca, Us -
Director Of Assay DevelopmentEpic Sciences │ The Power Of Clarity Aug 2020 - PresentSan Diego, Ca, UsBuilt-out and leading the assay development team focused on powerful proteomic solutions in the liquid biopsy cancer diagnostics space. Ongoing activities include:- Delivering on annual immunoassay strategic initiatives across multiple cancer types - Data analytics innovation, assay development risk mitigation, and reduced TAT- People management (up to 9 direct reports)- Next-gen technology sensing- Synergy via cross-functional team collaborations- See www.DefineMBC.com for latest offering: CTC immunofluorescence, CTC single-cell genomics, and cell-free DNA for TMB analysis -
Entrepreneur In Residence - Proteomic Innovation; Office Of The CsoThermo Fisher Scientific Feb 2020 - Aug 2020Waltham, Ma, UsReported directly to the Chief Scientific Officer with projects including:1) Corporate COVID-19 serology/antigen testing task force focusing on immunoassay diagnostics to address the SARS-CoV-2 pandemic. 2) Landscape analysis of high-content MS-based pathway proteomic biomarker discovery opportunities for the Precision Medicine Science Center, Cambridge, MA. -
Senior R&D Manager & Immunoassay Strategy Lead: High-Sensitivity Biomarker PlatformsThermo Fisher Scientific Mar 2016 - Jan 2020Waltham, Ma, Us- Technical and people leader of the R&D team responsible for development of the PLA-based Invitrogen ProQuantum High-Sensitivity Immunoassay platform. ProQuantum combines the target specificity of matched antibody pairs with the sensitivity of TaqMan qPCR amplification. Development of this powerful immunoassay platform also included creation of the ProQuantum Thermo Fisher Cloud app, which assists with assay setup, method documentation, and data analysis. As of January 2020, over 60 analyte-specific assays have been launched. See details at www.thermofisher.com/ProQuantum- Managed platform early-adopter relationships including translational investigators in inflammation, cancer and autoimmunity- Collaborated with product management on voice-of-customer (VOC), user-centered innovation (UCI) prototyping, adaptive-choice conjoint analysis, product configuration, COGS assessment, materials sourcing, pricing, and multi-generational product pipeline (MGPP) planning- Supported commercial activities through webinars, poster presentations, face-to-face meetings with end-users, and training sales as well as technical support teams - Served as the high-sensitivity protein quant technical domain expert consulting with other teams (including Scientific Advisory Board) across the corporation to aid with tech scouting and considerations for licensing as well as M&A -
Senior Staff Scientist And Immunoassay Strategy LeadThermo Fisher Scientific Aug 2015 - Mar 2016Waltham, Ma, UsBuilt team and managed R&D efforts on next-gen immunoassay platforms for translational investigators in inflammation, cancer, and autoimmunity. - Secured and managed KOL relationships fir next-gen immunoassay technologies- Managed antibody roadmap pipeline across multiple teams and sites -
Staff Scientist, Protein BiologyThermo Fisher Scientific Feb 2014 - Aug 2015Waltham, Ma, UsNote: same functional business unit as previously associated with Life Technologies prior to acquisition by Thermo Fisher Scientific. -Led R&D efforts on developing next-gen immunoassay platforms for translational investigators in inflammation, cancer, and autoimmunity- Company leader in revenue-generating Scientist-to-Scientist (S2S) activities (> $1M annual return on investment) including seminars, demos, and 1:1 engagements with end-users and principal investigators- Founding and current member of company-wide technology sensing team focusing on immunoassay platforms competing with western, ELISA, and multiplexed-based tools- Protein Biology moderator for the company-wide ideation/ crowd-sourcing tool critical to R&D ideation across our global organization -
Sr. Scientist, Protein BiologyLife Technologies Mar 2009 - Feb 2014Waltham, Ma, Us(Note: Life Technologies was acquired by Thermo Fisher Scientific in February of 2014)- Lead scientist for next-gen immunoassay development- Secured research grants (totaling $80K; funded by office of the Chief Scientific Officer) to establish external collaborations with translational researchers in the areas of cancer and inflammation. This work utilizes the combined power of multiplexed cytokine panels as well as the newly developed ProtoPlex™ immune response assay to identify predictive autoantibody/cytokine biomarker panels in autoimmunity and various forms of cancer.- Company leader in revenue-generating Scientist-to-Scientist (S2S) activities (> $1M annual return on investment) including seminars, demos, and 1:1 engagements with end-users and principal investigators- Core R&D team member responsible for developing and launching the ProtoPlex™ Luminex bead-based assay platform (http://www.lifetechnologies.com/us/en/home/life-science/protein-expression-and-analysis/biomarker-discovery/protoarray/protoplex-immune-response-assay.html) - Founding and current member of company-wide technology sensing team focusing on immunoassay platforms competing with western, ELISA, and multiplexed-based tools- Protein Biology moderator for the company-wide ideation/ crowd-sourcing tool critical to R&D ideation across our global organization- Extensive platform experience in NAPPA (nucleic acid programmable protein arrays) and ProtoArray™ Human Protein Microarrays -
Global Applications Scientist, Immunoassay AutomationPerkinelmer, Inc. Nov 2006 - Mar 2009Shelton, Ct, UsLead scientist for Luminex xMAP bead based multiplexing automation workflow development- Worked with new end-users (in some cases established new collaborative relationships) in molecular diagnostics, immunoassay screening, and drug development- Domain technical expert to field sales forceHigh pressure planar electrochromatography - member of interdisciplinary team that developed working breadboard for separation of peptides and proteins.Gave numerous podium presentations, workshops, and training classes at scientific conferencesAuthored technical reports, pre-sales materials (e.g. application notes & webinars), market analysis reports, and drafted high-profile requests for proposal (RFP) applications Identified new/emerging technologies for automation and liquid handling technology -
Postdoctoral FellowUniversity Of North Carolina At Chapel Hill School Of Medicine Sep 2001 - Oct 2006Chapel Hill, Nc, UsCharacterized P2Y1 receptor-induced platelet shape change, and receptor desensitization & internalization using a novel P2Y1 receptor-selective agonist developed in our laboratory.Developed an automated mammalian cell DNA transfection and screening assay (incorporating Biomek® FX liquid handling and a scintillation proximity assay) to search for regulators of phospholipase C isozymes.Studied regulation of human neutrophil function by the P2Y14 receptor.Extensive experience in molecular cloning, protein expression (receptors, G proteins, exchange factors, and phospholipase C isozymes; baculoviral/Sf9 insect, bacterial, and mammalian cultured cell lines) and purification via Äkta FPLC. -
Graduate Research AssistantUniversity Of Missouri School Of Medicine Jan 1995 - Jun 2001Columbia, Mo, UsIdentified two serotonin receptor subtypes expressed in the rat submandibular gland and characterized discrete patterns of receptor distribution in separate glandular areas via molecular biology and pharmacological techniques.Studied serotonin receptor activation in the isolated perfused rat submandibular gland. -
Research BiologistPfizer Jan 1995 - Nov 1995New York, New York, UsMonsanto/Searle - Discovery Pharmacology, Arthritis and Inflammation (now Pfizer). Supervisor: Dr. Daniela Salvemini.Research areas: 1) developed an in vivo rat model for acute bacterial endotoxemia to examine the roles constitutive and inducible nitric oxide synthase as well as peroxynitrite in inflammation and sepsis2) studied nitric oxide- and peroxynitrite-mediated inflammation in the rat paw model. -
Undergraduate Research FellowWashington University School Of Medicine In St. Louis Jun 1994 - Aug 1994St. Louis, Mo, UsFAS / FAS ligand mediated apoptosis -
Undergraduate Research FellowWashington University School Of Medicine In St. Louis Jun 1993 - Aug 1993St. Louis, Mo, UsFAS / FAS ligand mediated apoptosis -
Research InternPfizer Jun 1992 - Aug 1992New York, New York, UsNitric oxide mediated inflammatory disease research -
Research InternPfizer Jun 1991 - Aug 1991New York, New York, UsNitric oxide mediated Inflammatory disease research
David Bourdon Skills
David Bourdon Education Details
-
University Of North Carolina At Chapel Hill School Of MedicineGpcr Signalling And Thrombosis -
University Of Missouri-Columbia, School Of MedicinePharmacology -
Truman State UniversityBiology With Honors
Frequently Asked Questions about David Bourdon
What company does David Bourdon work for?
David Bourdon works for Aviva Systems Biology
What is David Bourdon's role at the current company?
David Bourdon's current role is Assay development leader empowering the biomedical community with innovative emerging technologies.
What is David Bourdon's email address?
David Bourdon's email address is da****@****mac.com
What is David Bourdon's direct phone number?
David Bourdon's direct phone number is +176091*****
What schools did David Bourdon attend?
David Bourdon attended University Of North Carolina At Chapel Hill School Of Medicine, University Of Missouri-Columbia, School Of Medicine, Truman State University.
What are some of David Bourdon's interests?
David Bourdon has interest in Sealfit, Autoantibody Biomarker Discovery, Protein Purification, Automated Cellular Screening, Intracellular Signaling, Thrombosis, Scientist To Scientist (S2s), Immunoassay Sensing, Pharmacology, Triathlon.
What skills is David Bourdon known for?
David Bourdon has skills like Molecular Biology, Protein Purification, Cell Biology, Cell, Biotechnology, Assay Development, Protein Chemistry, Biochemistry, Transfection, Immunoassays, Protein Expression, In Vivo.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial